KIND PHARMACEUTICAL

kind-pharmaceutical-logo

Kind Pharmaceutical is a clinical-stage biopharmaceutical company that focuses on the discovery and development of anemia drugs. The company was founded in 2013 and is headquartered in Redwood City, California, United States.

#SimilarOrganizations #Financial #Website #More

KIND PHARMACEUTICAL

Industry:
Biopharma Biotechnology Health Care Therapeutics

Founded:
2014-07-01

Address:
Hangzhou, Zhejiang, China

Country:
China

Website Url:
http://www.kindpharmaceuticals.com

Total Employee:
51+

Status:
Active

Contact:
+86 0571-89052795

Total Funding:
50 M USD

Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Mobile Non Scaleable Content Euro GoDaddy DNS Apple Mobile Web App Capable Pound Sterling Apple Mobile Web App Status Bar Style Japanese Yen Baidu Maps


Similar Organizations

aimmune-therapeutics-logo

Aimmune Therapeutics

Aimmune Therapeutics is a clinical-stage biopharmaceutical company that improves the lives of people with food allergies.

edgewise-therapeutics-logo

Edgewise Therapeutics

Edgewise Therapeutics is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization.

lynk-pharmaceuticals-logo

LYNK Pharmaceuticals

LYNK Pharmaceuticals is a biotech company focusing on the discovery and development of novel medicines.

Investors List

decheng-capital_image

Decheng Capital

Decheng Capital investment in Series B - Kind Pharmaceutical

banyan-capital_image

Gaorong Capital

Gaorong Capital investment in Series B - Kind Pharmaceutical

ancheng-capital_image

Ancheng Capital

Ancheng Capital investment in Series B - Kind Pharmaceutical

efung-capital_image

EFung Capital

EFung Capital investment in Series B - Kind Pharmaceutical

northern-light-venture-capital_image

Northern Light Venture Capital

Northern Light Venture Capital investment in Series B - Kind Pharmaceutical

Official Site Inspections

http://www.kindpharmaceuticals.com

  • Host name: 58.64.190.100
  • IP address: 58.64.190.100
  • Location: Hong Kong
  • Latitude: 22.25
  • Longitude: 114.1667
  • Timezone: Asia/Hong_Kong

Loading ...

More informations about "Kind Pharmaceutical"

Kind Pharmaceutical - Crunchbase Company Profile

Kind Pharmaceutical is a clinical-stage biopharmaceutical company that focuses on the discovery and development of anemia drugs. The company was …See details»

安道药业 - Kind Pharmaceuticals

Kind Pharmaceuticals LLC is a multinational pharmaceutical company with a US site located at the Pharmaceutical Research Center in San Francisco, and a China site founded in the …See details»

安道药业

10月1日,由安道药业自主研发的第三代口服乳腺癌1类新药and019,获美国fda临床批准。这是公司继其新型贫血新药and017于今年初被美国fda批准临床ii期后,又一个获批全球临床开发的创 …See details»

Kind Pharmaceuticals LLC - Dun & Bradstreet

Find company research, competitor information, contact details & financial data for Kind Pharmaceuticals LLC of Redwood City, CA. Get the latest business insights from Dun & …See details»

安道药业 - Kind Pharmaceuticals

Pandy Song, joined NLVC in 2016 and brought with him a profound understanding of China’s pharmaceutical industry. He has extensive experience in corporate strategic planning and …See details»

Kind Pharmaceutical Company Profile 2025: Valuation, …

Kind Pharmaceutical General Information Description. Develoepr of drugs and treatments for kidney disease and cancer. The main research project of the company is the self-developed oral small molecule compound AND017, …See details»

Kind Pharmaceuticals - Overview, News & Similar companies

Apr 15, 2024 Kind Pharmaceuticals contact info: Phone number: (650) 307-6151 Website: www.kindpharmaceuticals.com What does Kind Pharmaceuticals do? Kind Pharmaceuticals …See details»

Kind Pharmaceuticals LLC - Drug pipelines, Patents, Clinical trials ...

Nov 9, 2024 Explore Kind Pharmaceuticals LLC with its drug pipeline, therapeutic area, technology platform, .See details»

Kind Pharmaceutical - Products, Competitors, Financials, …

Kindpharmaceuticals.com. Overview & Products; Financials; Founded Year 2014. Stage Series B | Alive. Total Raised $50M. Last Raised $50M | 3 yrs ago. About Kind Pharmaceutical. Kind …See details»

安道药业 - kindpharmaceuticals.com

Xikai Zhao (Director of Hangzhou Science and Tehcnology Bureau), Hongdan Zhu (Member of the Standing Committee of Yuhang District, Organization Minister), Dong Liu (CEO of Kind …See details»

Kind Pharmaceutical Company Profile: Overview and Full News …

Kindpharmaceuticals.com. Overview: Kind Pharmaceutical. Kind Pharmaceutical, based in Zhejiang, is a leading company in the pharmaceutical industry. They specialize in the …See details»

Kind Pharmaceuticals LLC Asset Profile | Preqin

Www.kindpharmaceuticals.com Company Stage Series B Total Amount Raised Subscriber access only Time to go Pro Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on …See details»

Kind Pharmaceutical Stock Price, Funding, Valuation, Revenue ...

Dec 27, 2021 kindpharmaceuticals.com. Overview & Products; Financials; Total Raised $50M. Investors Count 6. Funding, Valuation & Revenue. 3 Fundings. Kind Pharmaceutical has …See details»

安道药业 - Kind Pharmaceuticals

Dr. Yi ng ping Jiang, Ph.D., joined Kind as Chief Biological Officer (CBO) in 2022 with nearly 30 years of extensive experience in antibody development in both biotech and pharmaceutical …See details»

Kind Therapeutics Usa, LLC - Dun & Bradstreet

Find company research, competitor information, contact details & financial data for Kind Therapeutics Usa, LLC of Olney, MD. Get the latest business insights from Dun & Bradstreet.See details»

Kind Pharmaceuticals Announces Settlement - Yahoo Finance

Apr 16, 2024 Today, Hangzhou Andao Pharmaceutical Ltd. and Kind Pharmaceuticals LLC ("Kind Pharmaceuticals"), together with its Chief Executive Officer Dr. Dong Liu and Chief …See details»

安道药业 - Kind Pharmaceuticals

The four clinical trials are first-in-human trial in healthy subjects.See details»

Strengthening the R&D operating model | McKinsey - McKinsey

1 day ago These initial areas will depend on the organization’s starting point, pipeline context, and aspirations. But one place to start is establishing a robust baseline of the company’s …See details»

安道药业 - Kind Pharmaceuticals

On October 1st, the third-generation oral breast cancer new drug, AND019, independently developed by Kind Pharmaceuticals LLC has received IND approval by the US FDA.See details»

linkstock.net © 2022. All rights reserved